Candriam Equities L Biotech.R EUR Acc/ LU1269736838 /
| NAV2024-07-25 | Chg.+3.6000 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 360.1900EUR | +1.01% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 3.24 | 8.73 | -8.18 | 11.89 | -1.92 | 3.11 | -10.47 | 12.83 | -2.22 | - |
| 2017 | 3.03 | 8.72 | -0.49 | -0.67 | -5.96 | 7.91 | -0.89 | 5.99 | 1.53 | -5.17 | -2.11 | 0.80 | +12.13% |
| 2018 | 2.91 | -2.52 | -2.89 | -1.42 | 8.33 | 0.84 | 4.25 | 4.77 | -1.87 | -11.81 | 4.26 | -9.14 | -6.05% |
| 2019 | 12.77 | 4.42 | 0.90 | -4.71 | -3.87 | 7.14 | 0.09 | -1.23 | -3.48 | 8.72 | 13.36 | 1.02 | +38.52% |
| 2020 | -4.00 | -0.60 | -4.83 | 12.62 | 7.87 | 0.37 | -7.82 | -0.23 | 2.77 | -1.95 | 6.65 | 0.73 | +10.25% |
| 2021 | 2.59 | -2.45 | -1.09 | 0.34 | -3.37 | 9.30 | -1.40 | 4.43 | -2.41 | 0.36 | -1.64 | 1.42 | +5.54% |
| 2022 | -9.24 | -1.70 | 7.12 | -2.10 | -5.38 | 6.12 | 7.42 | 3.02 | 0.75 | 5.62 | 1.98 | -6.23 | +5.80% |
| 2023 | 1.20 | -3.34 | -2.09 | 0.70 | 2.65 | -0.83 | -1.56 | 1.42 | -2.03 | -5.90 | 2.91 | 12.30 | +4.44% |
| 2024 | 3.27 | 1.79 | 0.23 | -5.24 | 2.33 | 7.08 | 5.60 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.12% | 16.01% | 16.41% | 20.25% | 23.05% |
| Sharpe ratio | 1.59 | 1.25 | 1.30 | 0.28 | 0.37 |
| Best month | +12.30% | +7.08% | +12.30% | +12.30% | +13.36% |
| Worst month | -5.24% | -5.24% | -5.90% | -9.24% | -9.24% |
| Maximum loss | -9.45% | -9.45% | -10.42% | -19.49% | -27.31% |
| Outperformance | -2.53% | - | -0.31% | - | - |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,286.9800 | +22.63% | +17.56% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 243.7100 | +23.94% | +27.10% | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,281.9399 | +20.02% | +9.12% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,456.6499 | +24.63% | +27.49% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,725.7200 | +22.30% | +24.47% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 391.8100 | +22.77% | +28.77% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 360.1900 | +25.10% | +30.50% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 221.7800 | +17.46% | +7.23% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 2,051.3999 | +23.27% | +20.87% | |
| Candriam Equities L Biotechnolog... | reinvestment | 165.2000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 665.2100 | +21.44% | +15.58% | |
| Candriam Equities L Biotech.I US... | reinvestment | 6,255.2002 | +22.48% | +17.13% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 218.3800 | +19.44% | +8.94% | |
| Candriam Equities L Biotech.R US... | reinvestment | 297.2000 | +22.96% | +19.96% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 228.0600 | +20.44% | +11.65% | |
| Candriam Equities L Biotechnolo... | reinvestment | 934.3600 | +21.88% | +17.02% | |
| Candriam Equities L Biotechnolog... | paying dividend | 853.2800 | +21.84% | +16.91% |
Performance
| YTD | +15.51% | ||
|---|---|---|---|
| 6 Months | +11.22% | ||
| 1 Year | +25.10% | ||
| 3 Years | +30.50% | ||
| 5 Years | +78.23% | ||
| 10 Years | - | ||
| Since start | +140.13% | ||
| Year | |||
| 2023 | +4.44% | ||
| 2022 | +5.80% | ||
| 2021 | +5.54% | ||
| 2020 | +10.25% | ||
| 2019 | +38.52% | ||
| 2018 | -6.05% | ||
| 2017 | +12.13% | ||
